5-LO and leukotriene signaling may also be capable of shaping the TME through inducing the migration and activation of immune cells, production of growth factors, secretion of proinflammatory mediators and angiogenic factors; they may also directly interact with blood and lymphatic endothelium and influence the migration of cancer cells (Figure 3). This evidence concerns the gene ALOX5 and cancer.